VGLL4 promotes hepatocellular carcinoma progression via the Wnt/β-catenin pathway

Key Points

• Hepatocellular carcinoma progression is significantly influenced by VGLL4 activity, highlighting its role as a potential target.
• The study observed enhanced tumor growth associated with elevated levels of VGLL4 and alterations in the wnt/β-catenin pathway.
• Analysis of cellular models demonstrated that VGLL4 interacts directly with the wnt pathway, leading to increased beta-catenin activity.
• These findings may enable novel therapeutic strategies targeting VGLL4 to manage hepatocellular carcinoma, but further studies are needed.